Immunostimulation of Patients With Head and Neck Cancer: In Vitro and Preliminary Clinical Experiences
- 1 May 1983
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 109 (5), 298-301
- https://doi.org/10.1001/archotol.1983.00800190020005
Abstract
• The development of malignancy is theorized to be from failure of the immunosurveillance system. Prostaglandins (PGs), synthesized by a mononuclear cell, tumor cell, or both, enhance inhibition of competent cellular immunity. Ten patients with terminal squamous cell carcinoma of the head and neck were treated with indomethacin, an inhibitor of PG synthesis. Two patients had a dramatic response; however, an in vitro assay and a derived-stimulation index did not correlate with the clinical response. A review of the literature and future directions are discussed. (Arch Otolaryngol 1983;109:298-301)This publication has 9 references indexed in Scilit:
- Regression of Head and Neck Carcinoma With a Prostaglandin-Synthesis InhibitorJAMA Otolaryngology–Head & Neck Surgery, 1981
- Regulation of the immune response by prostaglandinsClinical Immunology and Immunopathology, 1980
- Tumor Growth Inhibition and Potentiation of Immunotherapy by Indomethacin in Mice2JNCI Journal of the National Cancer Institute, 1979
- A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cellsCellular Immunology, 1978
- Enhancement of Carcinogenesis by Prostaglandins in Male Albino Swiss Mice2JNCI Journal of the National Cancer Institute, 1978
- PROSTAGLANDINS AND BREAST CANCERThe Lancet, 1977
- Prostaglandin synthesis inhibition: Effect on bone changes and sarcoma tumor induction in balb/c miceInternational Journal of Cancer, 1975
- Immunological defect in aged population and its relationship to cancerCancer, 1965